2014
DOI: 10.3390/ijms15022119
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis Signal Regulating Kinase 1 (ASK1): Potential as a Therapeutic Target for Alzheimer’s Disease

Abstract: Alzheimer’s disease (AD) is the most common form of dementia, characterized by a decline in memory and cognitive function. Clinical manifestations of AD are closely associated with the formation of senile plaques and neurofibrillary tangles, neuronal loss and cognitive decline. Apoptosis signal regulating kinase 1 (ASK1) is a mediator of the MAPK pathway, which regulates various cellular responses such as apoptosis, cell survival, and differentiation. Accumulating evidence indicates that ASK1 plays a key role … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
38
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(39 citation statements)
references
References 84 publications
0
38
1
Order By: Relevance
“…Accumulating evidence suggests that ASK1 may contribute to the pathogenesis of AD and other neurodegenerative disorders by regulating various cellular responses such as apoptosis, cell survival, and differentiation (Song et al ., 2014). …”
Section: Discussionmentioning
confidence: 99%
“…Accumulating evidence suggests that ASK1 may contribute to the pathogenesis of AD and other neurodegenerative disorders by regulating various cellular responses such as apoptosis, cell survival, and differentiation (Song et al ., 2014). …”
Section: Discussionmentioning
confidence: 99%
“…ASK1, a protein kinase of the mitogen-activated protein kinase kinase kinase (MAPKKK) family that initiates the JNK and p38 MAPK signaling cascades is involved in several cellular responses like apoptosis, cell survival, and differentiation. Since it is also activated in response to several stresses including TNF, ER stress, and H 2 O 2 , it is the potential therapeutic target currently [95].…”
Section: Proteins and Peptidesmentioning
confidence: 99%
“…1 Conversely the ER stress pathway can activate tau kinases such as apoptosis signal-regulating kinase 1, JNK, and glycogen synthase kinase-3b (GSK3b). 8,38,48 These important costimulatory interactions connect ER stress in interplay with chronic neurodegenerative diseases. In addition, phosphorylated PERK has been colocalized with tau in diseases such as Alzheimer's disease and supranuclear palsy.…”
mentioning
confidence: 99%